助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   neurogenic incontinence 的翻译结果: 查询用时:0.185秒
图标索引 在分类学科中查询
所有学科
泌尿科学
更多类别查询

图标索引 历史查询
 

neurogenic incontinence
相关语句
  神经原性尿失禁
     Botulinum-A toxin injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in patients with spinal cord injury
     经尿道膀胱壁A型肉毒毒素注射治疗脊髓损伤患者逼尿肌反射亢进及神经原性尿失禁
短句来源
     Objective To evaluate the effects of Botulinum-A toxin (BTX-A) injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in the patients with spinal cord injury (SCI).
     目的 评估逼尿肌A型肉毒毒素注射治疗脊髓损伤患者逼尿肌反射亢进和神经原性尿失禁的临床效果。
短句来源
     Conclusions Our initial experience suggests that Botulinum-A toxin injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in patients with SCI may be an effective,safe,feasible and micro-invasive treatment choice. However,it is necessary to observe its long term outcome.
     结论 逼尿肌A型肉毒毒素注射是一种治疗脊髓损伤患者逼尿肌反射亢进和神经原性尿失禁的有效、安全、可行、可重复的微创方法。
短句来源
  “neurogenic incontinence”译为未确定词的双语例句
     Botulinum toxin type A repeated injections into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in spinal cord injury patients: 6 cases report
     逼尿肌A型肉毒毒素重复注射治疗脊髓损伤后逼尿肌反射亢进及神经源性尿失禁
短句来源
     Clinical Therapy and Recovery Training of Overactive Neurogenic Incontinence
     反射亢进型神经源性尿失禁的临床治疗与康复
短句来源
     The Perioperative Complication and It's Treatment for Feces and Urine Neurogenic Incontinence
     神经源性大小便失禁围手术期并发症及处理
短句来源
     The urodynamics and image results show that the patient with overactive neurogenic incontinence has low capacity, pelvic floor ptosis, low compliance and more than 15cmH2O detrusor contraction in the bladder filling stage.
     反射亢进型神经源性尿失禁的病因是由于脊髓骶髓以上的中枢神经系统受到损伤所造成的。 其主要的影像学及尿流动力学结果为:膀胱容量小、膀胱外形呈松塔样、大多数合并盆底肌松驰,膀胱顺应性低,膀胱充盈期有逼尿肌不自主收缩收缩幅度大于15cmH2O。
短句来源
     Methods Retrospective analysis was made for the major perioperative complications of 96 patients with feces and urine neurogenic incontinence in the perioperative treatment,the causes of complications were analysed respectively.
     方法 回顾性分析96例接受手术治疗的神经源性大小便失禁患者围手术期主要并发症 ,逐一分析其发生原因。
短句来源
更多       
  相似匹配句对
     Treatment and recovery of neurogenic fecal incontinence in children
     小儿神经源性排便失禁的外科治疗与术后康复协调训练
短句来源
     The Perioperative Complication and It's Treatment for Feces and Urine Neurogenic Incontinence
     神经源性大小便失禁围手术期并发症及处理
短句来源
     Secretoneurin and neurogenic inflammation
     Secretoneurin和神经原性炎症(英文)
短句来源
     Neurogenic Myositis Ossificans
     神经源性骨化性肌炎
短句来源
     STRESS INCONTINENCE OF URINE
     压力性尿失禁
短句来源
查询“neurogenic incontinence”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  neurogenic incontinence
Patients with endoanal ultrasound sphincter defects also did better than those with primary neurogenic incontinence (p=0.02).
      
Incontinence associated with previous colonic and rectal resection or perianal surgery responded significantly better to the training than patients with primary neurogenic incontinence (p=0.001).
      
PURPOSE: The study was undertaken to determine whether idiopathic fecal incontinence in middle-aged and elderly females is likely to be a result of pudendal nerve damage (neurogenic incontinence) or merely a consequence of aging.
      
PURPOSE: Patients with idiopathic or neurogenic incontinence without an isolated sphincter defect may be suitable candidates for a postanal repiar.
      
We performed a randomized trial comparing postanal and total pelvic floor repair for neurogenic incontinence.
      
更多          


Objective To investigate the effective measure reducing perioperative complications and enhancing curative effect of the feces and urine neurogenic incontinence.Methods Retrospective analysis was made for the major perioperative complications of 96 patients with feces and urine neurogenic incontinence in the perioperative treatment,the causes of complications were analysed respectively.Results There was not operative death in this series,the postoperative complications were as follows:18 cases...

Objective To investigate the effective measure reducing perioperative complications and enhancing curative effect of the feces and urine neurogenic incontinence.Methods Retrospective analysis was made for the major perioperative complications of 96 patients with feces and urine neurogenic incontinence in the perioperative treatment,the causes of complications were analysed respectively.Results There was not operative death in this series,the postoperative complications were as follows:18 cases of the perineal incision infection in the part of attachment department of iliopsoas occured,vesical fistula occured in 4 cases,urinary infection occured in 2 cases.The postoperative fouowed-up of feces and urine incontinence was evaluated as 4,3,2,1,0 score respectively,and the numbers of the patients were 28,37,23,4,4 respectively;The interval of urination exceeded 30 minutes in 58 cases,the frequency of dripping urination had reduced in 30 cases,8 cases had not improved.Conclusions The key measure of reducing perioperative complications of patients with feces and urine neurogenic incontinence was a combining treatment,it is helpful for enhancing long term curative effect by reducing perioperative complications.

目的 探讨降低神经源性大小便失禁围手术期并发症、提高疗效的有效措施。方法 回顾性分析96例接受手术治疗的神经源性大小便失禁患者围手术期主要并发症 ,逐一分析其发生原因。结果 全组无手术死亡 ,术后并发症分别为 :会阴部髂腰肌附着部切口感染 18例 ,膀胱瘘 4例 ,泌尿系感染 2例。术后随访大便失禁 ,评价结果 :分别是 4分钟者 2 8例 ,3分者 37例 ,2分者 2 3例 ,1分、0分者各 4例 ;小便失禁评价结果分别是 :排尿间隔 30min以上者 5 8例 ,尿淋离次数减少者 30例 ,无改善 8例。结论 降低神经源性大小便失禁围手术期并发症的关键在于综合处理 ,并发症的降低有利于提高远期疗效。

Objective To evaluate the effects of Botulinum-A toxin (BTX-A) injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in the patients with spinal cord injury (SCI). Methods A total of 31 patients with SCI(mean age,30 years;male 20,female 11) were included into the study.All the patients underwent urodynamic examination and voiding diary was recorded.300 U of BTX-A was dissolved in 15 ml of saline,and the solution of BTX-A was injected into 30 different points in detrusor...

Objective To evaluate the effects of Botulinum-A toxin (BTX-A) injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in the patients with spinal cord injury (SCI). Methods A total of 31 patients with SCI(mean age,30 years;male 20,female 11) were included into the study.All the patients underwent urodynamic examination and voiding diary was recorded.300 U of BTX-A was dissolved in 15 ml of saline,and the solution of BTX-A was injected into 30 different points in detrusor using a flexible cystoscopic needle.The evaluation for the effects and follow-up included voiding diary,urodynamic testing and observation of adverse and toxic effects. Results After the first injection,29 of the 31 patients had symptom relief within 3 to 14 days;4 cases received the second injection;4 cases were treated in combination with anticholinergic medication;and 2 cases had no improvement and,therefore,received other treatments.The mean follow-up was 8.5 months. After 3-week treatment of BTX-A,the mean frequency of incontinence decreased from 14.2 to 2.5 times per day.The mean volume of intermittent catheterization (IC) increased from 124 to 495 ml each time.Urodynamic data showed that mean cystometric bladder storage volume increased from 133 to 475 ml,mean maximum storage detrusor pressure decreased from 62.7 to 17.1 cmH 2O(1 cmH 2O=0.098 kPa).No adverse and toxic effect was observed. Conclusions Our initial experience suggests that Botulinum-A toxin injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in patients with SCI may be an effective,safe,feasible and micro-invasive treatment choice.However,it is necessary to observe its long term outcome.

目的 评估逼尿肌A型肉毒毒素注射治疗脊髓损伤患者逼尿肌反射亢进和神经原性尿失禁的临床效果。 方法 损伤平面在骶髓以上的完全性脊髓损伤患者 31例 ,男 2 0例、女 11例 ,平均年龄 30岁。均表现为肾积水、输尿管返流及严重尿失禁。将 30 0UA型肉毒毒素溶解于 15ml生理盐水 ,使用膀胱镜注射针分 30个点注射于三角区以外的膀胱壁 ,0 .5ml/点。治疗前后记录排尿日记、行尿动力学检查 ,并观察毒副作用。 结果 治疗后第 3周 ,31例平均尿失禁次数由 14 .2次 /d降至 2 .5次 /d ,平均导尿量由 12 4ml/次增至 4 95ml/次 ,尿动力学结果表明平均最大膀胱测压容积由 133ml增至 4 75ml、平均充盈末逼尿肌压力由 6 2 .7cmH2 O(1cmH2 O =0 .0 98kPa)降至 17.1cmH2 O。起效平均时间为 6 .8d(3~ 14d) ,6 .5 % (2 /31)患者因治疗后症状无改善改用其它方法 ,12 .9% (4 /31)患者因症状再次加重而接受第 2次肉毒素治疗 ,12 .9% (4 /31)患者因症状改善有限而同时服用托特罗定治疗。随访 1~ ...

目的 评估逼尿肌A型肉毒毒素注射治疗脊髓损伤患者逼尿肌反射亢进和神经原性尿失禁的临床效果。 方法 损伤平面在骶髓以上的完全性脊髓损伤患者 31例 ,男 2 0例、女 11例 ,平均年龄 30岁。均表现为肾积水、输尿管返流及严重尿失禁。将 30 0UA型肉毒毒素溶解于 15ml生理盐水 ,使用膀胱镜注射针分 30个点注射于三角区以外的膀胱壁 ,0 .5ml/点。治疗前后记录排尿日记、行尿动力学检查 ,并观察毒副作用。 结果 治疗后第 3周 ,31例平均尿失禁次数由 14 .2次 /d降至 2 .5次 /d ,平均导尿量由 12 4ml/次增至 4 95ml/次 ,尿动力学结果表明平均最大膀胱测压容积由 133ml增至 4 75ml、平均充盈末逼尿肌压力由 6 2 .7cmH2 O(1cmH2 O =0 .0 98kPa)降至 17.1cmH2 O。起效平均时间为 6 .8d(3~ 14d) ,6 .5 % (2 /31)患者因治疗后症状无改善改用其它方法 ,12 .9% (4 /31)患者因症状再次加重而接受第 2次肉毒素治疗 ,12 .9% (4 /31)患者因症状改善有限而同时服用托特罗定治疗。随访 1~ 15个月 ,平均 8.5个月。随访期未观察到任何毒副作用。 结论 逼尿肌A型肉毒毒素注射是一种治疗脊髓损伤患者逼尿肌反射亢进和神经原性尿失禁的有效、安全、可行、可重复的微创方法。

ObjectiveTo evaluate the effects of Botulinum toxin type A(BTX-A) repeated injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in spinal cord injury(SCI) patients.Methods6 patients with SCI were included into the study.300 U of BTX-A was dissolved in saline 15 ml,and injected into 30 different sites in detrusor using a flexible cystoscopic needle.BTX-A injection was repeated 3 times for all the patients.Urodynamic examination,voiding diary and toxic effects were recorded.ResultsThe...

ObjectiveTo evaluate the effects of Botulinum toxin type A(BTX-A) repeated injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in spinal cord injury(SCI) patients.Methods6 patients with SCI were included into the study.300 U of BTX-A was dissolved in saline 15 ml,and injected into 30 different sites in detrusor using a flexible cystoscopic needle.BTX-A injection was repeated 3 times for all the patients.Urodynamic examination,voiding diary and toxic effects were recorded.ResultsThe improvement for symptoms was observed within 5 to 21 days.The effects of injections lasted averagely 8.9 and 5.8 months for each injection.After the first injection,the mean frequency of incontinence decreased from 10.1 /d to 3.3 /d.The mean volume of intermittent catheterization(IC) increased from 98.5 ml to 404.2 ml each time.Mean cystometric volume increased from 95.4 ml to 385.6 ml,mean maximum storage detrusor pressure decreased from 105.8 cmH_2O to 31 cmH_2O.After the second injection,the mean frequency of incontinence decreased from 9.7 /d to 3.7 /d.The mean volume of IC increased from 108.3 ml to 387.2 ml each time.Mean cystometric bladder storage volume increased from 105.4 ml to 375.6 ml.Mean maximum storage detrusor pressure decreased from 97.8 cmH_2O to 33 cmH_2O.After the third injection,the mean frequency of incontinence decreased from 9.2 /d to 3.9 /d.The mean volume of IC increased from 115.7 ml to 363.9 ml each time.Mean cystometric volume increased from 102 ml to 357.6 ml.Mean maximum storage detrusor pressure decreased from 98.1 cmH_2O to 36.9 cmH_2O.The patients were followed up for 6 months.No adverse and toxic effect was observed.ConclusionBotulinum toxin type A repeated injection into detrusor is effective,safe,feasible and mini-invasive to treat detrusor hyperreflexia and neurogenic incontinence in patients with SCI.Botulinum toxin type A repeated injection into detrusor is effective,safe,feasible and mini-invasive to treat detrusor hyperreflexia and neurogenic incontinence in patients with SCI.

目的评价经尿道膀胱壁逼尿肌A型肉毒毒素重复注射治疗脊髓损伤患者逼尿肌反射亢进和神经源性尿失禁的临床效果。方法损伤平面在骶髓以上的完全性脊髓损伤患者6例,均有单侧或双侧肾积水,严重尿失禁,口服抗胆碱药物治疗效果不理想。将300 U A型肉毒毒素经膀胱镜注射针分30个点注射于除膀胱颈和三角区以外的膀胱壁。重复注射3次。治疗前后行影像尿动力学检查,并记录排尿日记,观察毒副作用。结果重复注射3次平均起效时间10.5 d(5~21 d),3次注射间隔时间分别平均为8.9个月和5.8个月。第1次注射后平均尿失禁次数由10.1/d降至3.3/d,平均导尿量由98.5 ml/次增至404.2 ml/次,平均最大膀胱测压容积由95.4 ml增至385.6 ml,平均充盈末逼尿肌压力由105.8 cmH2O降至31 cmH2O。第2次注射后平均尿失禁次数由9.7/d降至3.7/d,平均导尿量由108.3 ml/次增至387.2 ml/次,平均最大膀胱测压容积由105.4 ml增至375.6 ml,平均充盈末逼尿肌压力由97.8 cmH2O降至33 cmH2O。第3次注射后平均尿失禁次数由9.2/d降至3.9/d,平均导尿量由11...

目的评价经尿道膀胱壁逼尿肌A型肉毒毒素重复注射治疗脊髓损伤患者逼尿肌反射亢进和神经源性尿失禁的临床效果。方法损伤平面在骶髓以上的完全性脊髓损伤患者6例,均有单侧或双侧肾积水,严重尿失禁,口服抗胆碱药物治疗效果不理想。将300 U A型肉毒毒素经膀胱镜注射针分30个点注射于除膀胱颈和三角区以外的膀胱壁。重复注射3次。治疗前后行影像尿动力学检查,并记录排尿日记,观察毒副作用。结果重复注射3次平均起效时间10.5 d(5~21 d),3次注射间隔时间分别平均为8.9个月和5.8个月。第1次注射后平均尿失禁次数由10.1/d降至3.3/d,平均导尿量由98.5 ml/次增至404.2 ml/次,平均最大膀胱测压容积由95.4 ml增至385.6 ml,平均充盈末逼尿肌压力由105.8 cmH2O降至31 cmH2O。第2次注射后平均尿失禁次数由9.7/d降至3.7/d,平均导尿量由108.3 ml/次增至387.2 ml/次,平均最大膀胱测压容积由105.4 ml增至375.6 ml,平均充盈末逼尿肌压力由97.8 cmH2O降至33 cmH2O。第3次注射后平均尿失禁次数由9.2/d降至3.9/d,平均导尿量由115.7 ml/次增至363.9 ml/次,平均最大膀胱测压容积由102 ml增至357.6 ml,平均充盈末逼尿肌压力由98.1cmH2O降至36.9cmH2O。随访6个月,未观察到明显毒副作用。结论逼尿肌A型肉毒毒素重复注射是治疗脊髓损伤患者逼尿肌反射亢进和神经源性尿失禁的一种有效、安全的微创方法。

 
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关neurogenic incontinence的内容
在知识搜索中查有关neurogenic incontinence的内容
在数字搜索中查有关neurogenic incontinence的内容
在概念知识元中查有关neurogenic incontinence的内容
在学术趋势中查有关neurogenic incontinence的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社